MillerKnoll (MLKN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Achieved year-over-year sales growth in fiscal 2025, with net sales up 1.1% reported and 1.6% organically, despite a challenging macroeconomic environment.
Expanded product offerings in resilient sectors like healthcare and higher education, and opened new flagship showrooms in Chicago, London, and New York.
Retail expansion included four new stores in fiscal 2025, with plans to open 10–15 more in fiscal 2026, aiming to double the North American retail footprint over several years.
Published the 2024 Better World Report, highlighting progress in ESG initiatives and community engagement, including nearly 400 volunteer events in 2025.
Voting matters and shareholder proposals
Shareholders will vote on: election of three directors for three-year terms, advisory approval of executive compensation, ratification of KPMG LLP as independent auditor for fiscal 2026, and approval of the 2025 Long-Term Incentive Plan.
Board recommends voting “FOR” all proposals.
No shareholder proposals were submitted for the 2025 meeting.
Board of directors and corporate governance
Board consists of 11 directors (10 independent), with average tenure of 10.6 years; will reduce to 10 members after the 2025 meeting.
Three standing committees: Audit, Compensation, and Governance & Corporate Responsibility, all composed of independent directors.
Board governance guidelines require majority independence, annual review of policies, and separation of CEO and Chair roles.
Director compensation includes a minimum 50% equity component, with annual fees and additional compensation for committee chairs.
Latest events from MillerKnoll
- Q3 FY2026 delivered sales growth, margin gains, and strong order momentum despite global risks.MLKN
Q3 202625 Mar 2026 - Margins and EPS rose in Q4 despite lower sales, with a strong outlook for FY2025.MLKN
Q4 20243 Feb 2026 - Order and backlog growth offset lower sales; FY2025 adjusted EPS guidance reaffirmed.MLKN
Q1 202520 Jan 2026 - Q2 net sales up 2.2% to $970.4M, strong Americas growth, adjusted EPS $0.55, guidance narrowed.MLKN
Q2 202510 Jan 2026 - Orders rose 5.5% and gross margin hit 39.0%, offsetting a 1.6% sales decline.MLKN
Q2 20265 Jan 2026 - $130M impairment drove Q3 loss, but retail orders and guidance remain strong.MLKN
Q3 202526 Dec 2025 - Profitability improved, global reach expanded, and sustainability advanced; all proposals recommended for approval.MLKN
Proxy Filing1 Dec 2025 - Key votes: director elections, executive pay, auditor ratification, and incentive plan approval.MLKN
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay approval, and auditor ratification.MLKN
Proxy Filing1 Dec 2025